APA (7th ed.) Citation

Bennett, C. L., Hoque, S., Olivieri, N., Taylor, M. A., Aboulafia, D., Lubaczewski, C., . . . Smith, W. K. (2021). Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR). Elsevier.

Chicago Style (17th ed.) Citation

Bennett, Charles L., et al. Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997–2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR). Elsevier, 2021.

MLA (8th ed.) Citation

Bennett, Charles L., et al. Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997–2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR). Elsevier, 2021.